Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study 

OBJECTIVE: To evaluate the long-term efficacy of once-daily baricitinib 4 mg in patients with active RA who were either naïve to DMARDs or who had inadequate response (IR) to MTX. METHODS: Analyses of data from two completed 52-week, phase III studies, RA-BEGIN (DMARD-naïve) and RA-BEAM (MTX-IR), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S, Xie, Li, Jia, Bochao, Taylor, Peter C, Burmester, Gerd, Tanaka, Yoshiya, Elias, Ayesha, Cardoso, Anabela, Ortmann, Rob, Walls, Chad, Dougados, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121442/
https://www.ncbi.nlm.nih.gov/pubmed/33200220
http://dx.doi.org/10.1093/rheumatology/keaa576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121442/
https://www.ncbi.nlm.nih.gov/pubmed/33200220
http://dx.doi.org/10.1093/rheumatology/keaa576

Ejemplares similares